185
Views
15
CrossRef citations to date
0
Altmetric
Connective tissue diseases

Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sjögren's syndrome

, , , , , , , , & show all
Pages 626-632 | Received 05 Jul 2013, Accepted 27 Sep 2013, Published online: 05 Nov 2013

References

  • Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection. J Am Dent Assoc. 2008;139(3):291–9.
  • Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG. Saliva and growth factors: the fountain of youth resides in us all. J Dent Res. 1995;74(12):1826–32.
  • Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555–62.
  • Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T. Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl. 1993;500:126–30.
  • Heitz PU, Kasper M, van Noorden S, Polak JM, Gregory H, Pearse AG. Immunohistochemical localization of urogastrone to human duodenal and submandibular glands. Gut. 1978;19(15):408–13.
  • Thesleff I, Viinikka L, Saxén L, Lehtonen E, Perheentupa J. The parotid gland is the main source of human salivary epidermal growth factor. Life Sci. 1988;43(1):13–8.
  • Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T, Takahashi T. Epidermal growth factor in salivary glands –Epidermal growth factor and its receptor in human salivary glands- (in Japanese). Jibirinsho. 1992;85(5):805–14.
  • Noguchi S, Ohba Y, Oka T. Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol. 1991;260 (4 Pt 1):E620–5.
  • Fujisawa K, Miyamoto Y, Nagayama M. Basic fibroblast growth factor and epidermal growth factor reverse impaired ulcer healing of the rabbit oral mucosa. J Oral Pathol Med. 2003;32(6):358–66.
  • Rourk RM, Namiot Z, Sarosiek J, Yu Z, McCallum RW. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis. Am J Gastroenterol. 1994;89(2):237–44.
  • Playford RJ. Peptides and gastrointestinal mucosal integrity. Gut. 1995;37(5):595–7.
  • Rao RK, Thomas DW, Pepperl S, Porreca F. Salivary epidermal growth factor plays a role in protection of ileal mucosal integrity. Dig Dis Sci. 1997;42(10):2175–81.
  • Ma L, Wang WP, Chow JY, Yuen ST, Cho CH. Reduction of EGF is associated with the delay of ulcer healing by cigarette smoking. Am J Physiol Gastrointest Liver Physiol. 2000;278(1):G10–7.
  • Niall M, Ryan GB, O’Brien BM. The effect of epidermal growth factor on wound healing in mice. J Surg Res. 1982;33(2):164–9.
  • Brown GL, Nanney LB, Griffen J, Cramer AB, Yancey JM, Curtsinger LJ III, et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl J Med. 1989;321(2):76–9.
  • Adişen E, Aral A, Aybay C, Gürer MA. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis. Dermatology. 2008;217(3):235–40.
  • Dumbrigue HB, Sandow PL, Nguyen KH, Humphreys-Beher MG. Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89(6):710–6.
  • Epstein JB, Gorsky M, Guglietta A, Le N, Sonis ST. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer. 2000;89(11):2258–65.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.
  • Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994;11(1):3–11.
  • Slade GD. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol. 1997;25(4):284–90.
  • Ide R, Tsutsui A, Yamamoto R, Ueno K, Tsuneoka M, Mizoue T, et al. Evaluation of dental health- related quality of life -The reliability of the Japanese edition of Oral Health Impact Profile- (in Japanese). J Dent Hlth. 2002;52(1):36–42.
  • Yamazaki M, Inukai M, Baba K, John MT. Japanese version of the Oral Health Impact Profile (OHIP-J). J Oral Rehabil. 2007;34(3):159–68.
  • Ide R, Yamamoto R, Mizoue T. The Japanese version of the Oral Health Impact Profile (OHIP) – validation among young and middle-aged adults. Community Dent Health. 2006;23(3):158–63.
  • Hutson JM, Niall M, Evans D, Fowler R. Effect of salivary glands on wound contraction in mice. Nature. 1979;279(5716):793–5.
  • Koski H, Konttinen YT, Hietanen J, Tervo T, Malmström M. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome. J Rheumtol. 1997;24(10):1930–5.
  • Shiboski CH, Hodgson TA, Ship JA, Schiødt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(Suppl):S66.e1–19.
  • Kelly SM, Crampton J, Hunter JO. Decreased salivary epidermal growth factor in rheumatoid disease: a possible mechanism for increased susceptibility to gastric ulceration. Br Med J. 1990;301(6749):422–3.
  • Royce LS, Baum BJ. Physiologic levels of salivary epidermal growth factor stimulate migration of an oral epithelial cell line. Biochim Biophys Acta. 1991;1092(3):401–3.
  • Oudhoff MJ, Bolscher JG, Nazmi K, Kalay H, van't Hof W, Amerongen AV, et al. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 2008;22(11):3805–12.
  • Girdler NM, McGurk M, Aqual S, Prince M. The effect of epidermal growth factor mouthwash on cytotoxic-induced oral ulceration. A phase I clinical trial. Am J Clin Oncol. 1995;18(5):403–6.
  • Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res. 1999;19(3):201–11.
  • Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol. 2003;136(2):291–9.
  • Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol. 1999;83(4):390–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.